LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma-Reference-Cited by-同舟云学术

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma

Published:2023-12-07 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Nielsen Morten¹^ORCID,Monberg Tine¹^ORCID,Sundvold Vibeke²^ORCID,Albieri Benedetta¹^ORCID,Hovgaard Dorrit³,Petersen Michael Mørk³^ORCID,Krarup-Hansen Anders⁴,Met Özcan¹⁵^ORCID,Camilio Ketil²,Clancy Trevor⁶^ORCID,Stratford Richard⁶,Sveinbjornsson Baldur²^ORCID,Rekdal Øystein²^ORCID,Junker Niels⁴,Svane Inge Marie¹^ORCID

Affiliation:

1. National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

2. Lytix Biopharma, Oslo, Norway

3. Department of Orthopedic Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

4. Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark

5. Department of Health Technology, Technical University of Denmark, Lyngby, Denmark

6. NEC Oncoimmunity AS, Oslo, Norway

Funder

Lytix Biopharma

Norwegian Research Counci

Publisher

Informa UK Limited